Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)
Karl R. Karsch, Melitta B. Preisack, Rainer Baildon, Volker Eschenfelder, David Foley, Eulogio J. Garcia, Martin Kaltenbach, Christoph Meisner, Hans K. Selbmann, Patrick W. Serruys, Man F. Shiu, MartiVolume:
28
Year:
1996
Language:
english
DOI:
10.1016/s0735-1097(96)00343-9
File:
PDF, 877 KB
english, 1996